Sadhana Nitro Chem Ltd (SADHNANIQ)

📊 Quarterly Results (₹ Cr)

Revenue has shown sequential improvement, rising from ₹3 lakh in Sep 2025 to ₹27 lakh in Jun 2026, but remains volatile and minuscule in scale. Operating performance remains severely negative, with OPM worsening from -765% to -2.2% over the same period, indicating marginal operational stabilization rather than recovery. Net losses persist, though the magnitude has fluctuated without a clear downward trend. The financial trajectory reflects stabilization attempts rather than turnaround momentum, with profitability still distant and dependent on scale and margin improvement in core chemical operations.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on profitability or revenue targets in the latest filings. However, repeated emphasis on capital discipline, fund utilization accuracy, and governance reforms suggests a focus on structural stabilization. The board’s actions — including leadership appointments, capital raises, and EGMs — indicate active restructuring. While no financial targets were disclosed, the company is signaling a long-term repositioning, likely aiming to stabilize operations before pursuing margin-enhancing initiatives or strategic partnerships.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet shows a mixed picture: equity has modestly increased to ₹296 lakhs (from ₹33 lakhs in prior periods), while reserves remain stable and borrowings have slightly declined. Total assets have stabilized around ₹650-660 lakhs, suggesting no major asset expansion. The rights issue capital was fully deployed without deviation, reinforcing financial transparency. However, the small equity base and high reserve-to-equity ratio suggest limited reinvestment capacity. There is no evidence of aggressive deleveraging or capital return, indicating capital preservation rather than growth investment.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Promoter holding has swung dramatically — from 29.97% in Q2 FY26 to 60.9% in Q1 FY27 — likely due to a complex restructuring or buyback mechanism not detailed in summaries. FII and DII holdings remain negligible (<0.1%), with public shareholder count declining from 68,448 to 75,881, suggesting retail investor churn. The lack of institutional accumulation and persistent low float indicate limited market interest. No pledging or exit signals were disclosed, but the shareholder base remains highly concentrated and unstable post-restructuring.

⚖️ Peer Comparison — Chemicals

🔗 Peer Stock Analyses

⚠️ Risk Factors

1) Persistent operational losses and negative margins despite revenue growth, with no clear path to profitability. 2) Governance volatility due to frequent leadership changes and board-level appointments, raising execution continuity concerns. 3) Capital structure complexity from multiple fund raises and allotments, with small equity base potentially limiting future financing flexibility. 4) Low institutional ownership and volatile promoter holding may lead to stock illiquidity and heightened sensitivity to news.

📋 Recent Filings

• 🔴 Announcement2026-09-25Sadhana Nitrochem received trading approval for 67.5 million equity shares of Re. 1 each with distinctive numbers 2964694386 to 3032194385 under a pre…
• Announcement2026-09-25Sadhana Nitro Chem Ltd announced that its trading window closes on October 1, 2026, for 48 hours after the unaudited quarterly results for September 3…
• 🟡 sustainability report2026-09-07Sadhana Nitro Chem Ltd's FY2025-26 BRSR report details its sustainability initiatives, including hazardous waste management, water conservation, and r…
• 🟡 Board Meeting2026-09-07Sadhana Nitro Chem held its 53rd Annual General Meeting on September 30, 2026 via video conference, allowing remote e-voting and electronic participat…
• 🔴 annual report2026-09-07Sadhana Nitro Chem Ltd's 53rd AGM on September 30, 2026, will be held virtually via video conferencing with e-voting open September 27-29. Shareholder…
• 🟡 deviation variation2026-08-07Sadhana Nitrochem Limited confirmed no deviation in the utilization of funds raised through its March 12, 2026 rights issue, with the full ₹263.53 cro…
• Announcement2026-07-28Sadhana Nitrochem Limited announced that both BSE and NSE have granted in-principle approval for a preferential issue of 6.75 million equity shares at…
• Financial Results2026-06-25Sadhana Nitrochem Limited reported unaudited consolidated results for Q1 FY2025 ending June 30, 2025, showing total income of **₹3258 lakhs** and net …
• Financial Results2026-06-25Sadhana Nitrochem Limited announced that its trading window will close on July 1, 2026, for designated persons and their immediate relatives, remainin…
• regulation 312026-06-11No summary available

🧠 Analyst's Read

Sadhana Nitrochem is undergoing a high-risk restructuring with early signs of financial stabilization but no operational turnaround. Investors should monitor next-quarter results for margin improvement and management’s ability to convert revenue growth into sustainable profitability. Key near-term triggers include progress on core business revival and clarity on capital allocation strategy post-restructuring.

Based on filing content and financial data. Not a recommendation.